Thymidylate synthase and dihydropyrimidine dehydrogenase mRNA expression levels: Predictors for survival in colorectal cancer patients receiving adjuvant 5-fluorouracil

Clinical Cancer Research

Volumn 9, Issue 11, 2003, Pages 4116-4124

  Kornmann, Marko ^a   Schwabe, Wolfgang ^b   Sander, Silvia ^a   Kron, Martina ^a   Sträter, Jörn ^a   Polat, Sucan ^a   Kettner, Erika ^c   Weiser, Hans F ^d   Baumann, Wolfram ^e   Schramm, Harald ^f   Häusler, Peter ^b   Ott, Kati ^b   Behnke, Detlev ^b   Staib, Ludger ^a   Beger, Hans G ^a   Link, Karl H ^a  

^a UNIVERSITY OF ULM   (Germany)

^b Oncoscreen GmbH   (Germany)

^c Städtisches Klinikum   (Germany)

^d Diakoniekrankenhaus ^*  (Germany)

^e KLINIK AM EICHERT   (Germany)

^f Department of Surgery   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DIHYDROPYRIMIDINE DEHYDROGENASE; FLUOROURACIL; MESSENGER RNA; THYMIDYLATE SYNTHASE;

ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER CELL CULTURE; CANCER PATIENT; CANCER STAGING; CANCER SURVIVAL; CLINICAL TRIAL; COLORECTAL CANCER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

AGED; ANTIMETABOLITES, ANTINEOPLASTIC; CHEMOTHERAPY, ADJUVANT; COLONIC NEOPLASMS; DIHYDROURACIL DEHYDROGENASE (NADP); FEMALE; FLUOROURACIL; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; PROGNOSIS; RECTAL NEOPLASMS; RNA, MESSENGER; SURVIVAL ANALYSIS; THYMIDYLATE SYNTHASE; TRANSCRIPTION, GENETIC;

EID: 0141455146     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Midgley, R., and Kerr, D. Colorectal cancer. Lancet, 353: 391-399, 1999.
2. Greenlee, R. T., Murray, T., Bolden, S., and Wingo, P. A. Cancer statistics, 2000. CA - Cancer J. Clin., 50: 7-33, 2000.
3. Link, K. H., Staib, L., Kreuser, E. D., and Beger, H. G. Adjuvant treatment of colon and rectal cancer: impact of chemotherapy, radiotherapy, and immunotherapy on routine postsurgical patient management. Rec. Results Cancer Res., 142: 311-352, 1996.
4. Danenberg, P. V. Thymidylate synthetase: a target enzyme in cancer chemotherapy, Biochim. Biophys. Acta, 473: 73-92, 1977.
5. Santi, D. V., McHenry, C. S., and Sommer, H. Mechanism of interaction of thymidylate synthetase with 5-fluorodeoxyuridylate. Biochemistry, 13: 471-481, 1974.
6. Kornmann, M., Link, K. H., Lenz, H. J., Pillasch, J., Metzger, R., Butzer, U., Leder, G. H., Weindel, M., Safi, F., Danenberg, K. D., Beger, H. G., and Danenberg, P. V. Thymidylate synthase is a predictor for response and resistance in hepatic artery infusion chemotherapy, Cancer Lett., 118: 29-35, 1997.
7. Van Triest, B., Pinedo, H. M., Giaccone, G., and Peters, G. J. Downstream molecular determinants of response to 5-fluorouracil and antifolate thymidylate synthase inhibitors. Ann. Oncol., 11: 385-391, 2000.
8. Johnston, P. G., Fisher, E. R., Rockette, H. E., Fisher, B., Wolmark, N., Drake, J. C., Chabner, B. A., and Allegra, C. J. The role of thymidylate synthase expression in prognosis and outcome of adjuvant chemotherapy in patients with rectal cancer. J. Clin. Oncol., 12: 2640-2647, 1994.
9. Edler, D., Hallstrom, M., Johnston, P. G., Magnusson, I., Ragnhammar, P., and Blomgren, H. Thymidylate synthase expression: an independent prognostic factor for local recurrence, distant metastasis, disease-free and overall survival in rectal cancer. Clin. Cancer Res., 6: 1378-1384, 2000.
10. Diasio, R. B., and Johnson, M. R. Dihydropyrimidine dehydrogenase: its role in 5-fluorouracil clinical toxicity and tumor resistance. Clin. Cancer Res., 5: 2672-2673, 1999.
11. Allegra, C. J. Dihydropyrimidine dehydrogenase activity: prognostic partner of 5-fluorouracil? Clin. Cancer Res., 5: 1947-1949, 1999.
12. Salonga, D., Danenberg, K. D., Johnson, M., Metzger, R., Groshen, S., Tsao-Wie, D. D., Lenz, H. J., Leichman, C. G., Leichman, L., Diasio, R. B., and Danenberg, P. V. Colorectal tumors responding to 5-fluorouracil have low gene expression levels of dihydropyrimidine dehydrogenase, thymidylate synthase, and thymidine phosphorylase. Clin. Cancer Res., 6: 1322-1327, 2000.
13. Kornmann, M., Maruyama, H., Bergmann, U., Tangvoranuntakul, P., Beger, H. G., White, M. F., and Korc, M. Enhanced expression of the insulin receptor substrate-2 docking protein in human pancreatic cancer. Cancer Res., 58: 4250-4254, 1998.
14. Link, K. H., Staib, L., Bernhart, H., Kreuser, E. D., Suhr, P., Röttinger, E., and Beger, H. G. Acceptance and toxicity of postoperative adjuvant therapy in colon and rectal cancers. Onkologie, 20: 235-238, 1997.
15. Kornmann, M., Ishiwata, T., Beger, H. G., and Korc, M. Fibroblast growth factor-5 stimulates mitogenic signaling and is overexpressed in human pancreatic cancer: evidence for autocrine and paracrine actions. Oncogene, 15: 1417-1424, 1997.
16. Johnston, P. G., Liang, C. M., Henry, S., Chabner, B. A., and Allegra, C. J. Production and characterization of monoclonal antibodies that localize human thymidylate synthase in the cytoplasm of human cells and tissue. Cancer Res., 51: 6668-6676, 1991.
17. Johnston, P. G., Lenz, H. J., Leichman, C. G., Danenberg, K. D., Allegra, C. J., Danenberg, P. V., and Leichman, L. Thymidylate synthase gene and protein expression correlate and are associated with response to 5-fluorouracil in human colorectal and gastric tumors. Cancer Res., 55: 1407-1412, 1995.
18. Woodall, C. J., Watt, N. J., and Clements, G. B. Simple technique for detecting RNA viruses by PCR in single sections of wax embedded tissue. J. Clin. Pathol. (Lond.), 46: 276-277, 1993.
19. Masuda, N., Ohnishi, T., Kawamoto, S., Monden, M., and Okubo, K. Analysis of chemical modification of RNA from formalin-fixed samples and optimization of molecular biology application for such samples. Nucleic Acids Res., 27: 4436-4443, 1999.
20. Chomoczynski, K., and Sacchi, N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem., 162: 156-159, 1987.
21. Kornmann, M., Danenberg, K. D., Arber, N., Beger, H. G., Danenberg, P. V., and Korc, M. Inhibition of cyclin D1 expression in human pancreatic cancer cells is associated with increased chemosensitivity and decreased expression of multiple chemoresistance genes. Cancer Res., 59: 3505-3511, 1999.
22. Diasio, R. B., Danenberg, K., Johnson, M., and Danenberg, P. V. Quantitation of dihydropyrimidine dehydrogenase expression in tumor specimens of patients treated with 5-fluorouracil using a quantitative polymerase chain reaction assay. Proc. Am. Assoc. Cancer Res., 39: 188, 1998.
23. Lenz, H. J., Leichman, C. G., Danenberg, K. D., Danenberg, P. V., Groshen, S., Cohen, H., Laine, L., Crookes, P., Silberman, H., Baranda, J., Garcia, Y., Li, J., and Leichman, L. Thymidylate synthase mRNA level in adenocarcinoma of the stomach: a predictor for primary tumor response and overall survival. J. Clin. Oncol., 14: 176-182, 1996.
24. Leichman, C. G., Lenz, H. J., Leichman, L., Danenberg, K., Baranda, J., Groshen, S., Boswell, W., Metzger, R., Tan, M., and Danenberg, P. V. Quantitation of intratumoral thymidylate synthase expression predicts for disseminated colorectal cancer response and resistance to protracted-infusion fluorouracil and weekly leucovorin. J. Clin. Oncol., 15: 3223-3229, 1996.
25. Nita, M. E., Tominaga, O., Nagawa, H., Tsuruo, T., and Muto, T. Dihydropyrimidine dehydrogenase but not thymidylate synthase expression is associated with resistance to 5-fluorouracil in colorectal cancer. Hepatogastroenterology, 45: 2117-2122, 1998.
26. Cascinu, S., Aschele, C., Barni, S., Debernardis, D., Baldo, C., Tunesi, G., Catalano, V., Staccioli, M. P., Brenna, A., Muretto, P., and Catalano, G. Thymidylate synthase protein expression in advanced colon cancer: correlation with the site of metastasis and the clinical response to leucovorin-modulated bolus 5-fluorouracil. Clin. Cancer Res., 5: 1996-1999, 1999.
27. Paradiso, A., Simone, G., Petroni, S., Leone, B., Vallejo, C., Lacava, J., Romero, A., Machiavelli, M., De Lena, M., Allegra, C. J., and Johnston, P. G. Thymidylate synthase and p53 primary tumour expression as predictive factors for advanced colorectal cancer patients. Br. J. Cancer, 82: 560-567, 2000.
28. Takenoue, T., Nagawa, H., Matsuda, K., Fujii, S., Nita, M. E., Hatano, K., Kitayama, J., Tsuruo, T., and Muto, T. Relation between thymidylate synthase expression and survival in colon carcinoma, and determination of appropriate application of 5-fluorouracil by immunohistochemical method. Ann. Surg. Oncol., 7: 193-198, 2000.
29. Edler, D., Glimelius, B., Hallström, M., Jakobsen, A., Johnston, P. G., Magnusson, I., Ragnhammar, P., and Blomgren, H. Thymidylate synthase expression in colorectal cancer: a prognostic and predictive marker of benefit from adjuvant fluorouracil-based chemotherapy. J. Clin. Oncol., 20: 1721-1728, 2002.
30. Yamachika, T., Nakanishi, H., Inada, K., Tsukamoto, T., Kato, T., Fukushima, M., Inoue, M., and Tatematsu, M. A new prognostic factor for colorectal carcinoma, thymidylate synthase, and its therapeutic significance. Cancer (Phila.), 82: 70-77, 1998.
31. Geoffroy, F. J., Allegra, C. J., Sinha, B., and Grem, J. L. Enhanced cytotoxicity with interleukin-1α and 5-fluorouracil in HCT116 colon cancer cells. Oncol. Res., 6: 581-591, 1994.
32. Pritchard, D. M., Watson, A. J., Potten, C. S., Jackman, A. L., and Hickman, J. A. Inhibition by uridine but not thymidine of p53-dependent intestinal apoptosis initiated by 5-fluorouracil: evidence for the involvement of RNA perturbation. Proc. Natl. Acad. Sci. USA, 94: 1795-1799, 1997.
33. Etienne, M. C., Cheradame, S., Fischel, J. L., Formento, P., Dassonville, O., Renee, N., Schneider, M., Thyss, A., Demard, F., and Milano, G. Response to fluorouracil therapy in cancer patients: the role of tumoral dihydropyrimidine dehydrogenase activity. J. Clin. Oncol., 13: 1663-1670, 1995.
34. Takabayashi, A., Iwata, S., Kawai, Y., Kanai, M., Taki, Y., Takechi, T., and Fukushima, M. Dihydropyrimidine dehydrogenase activity and mRNA expression in advanced gastric cancer analyzed in relation to effectiveness of preoperative 5-fluorouracil-based chemotherapy. Int. J. Oncol., 17: 889-895, 2000.
35. Douillard, J. Y., Cunningham, D., Roth, A. D., Navarro, M., James, R. D., Karasek, P., Jandik, P., Iveson, T., Carmichael, J., Alakl, M., Gruia, G., Awad, L., and Rougier, P. Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicenter randomized trial. Lancet, 355: 1041-1047, 2000.
36. Saltz, L. B., Cox, J. V., Blanke, C., Rosen, L. S., Fehrenbacher, L., Moore, M. J., Maroun, J. A., Ackland, S. P., Locker, P. K., Pirotta, N., Elfring, G. L., and Miller, L. L. Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. Irinotecan Study Group. N. Engl. J. Med., 343: 905-914, 2000.